Substance Use Disorders
Sorozatcím:
Primer On;
Kiadó: OUP USA
Megjelenés dátuma: 2020. december 9.
Normál ár:
Kiadói listaár:
GBP 59.00
GBP 59.00
Az Ön ára:
25 647 (24 426 Ft + 5% áfa )
Kedvezmény(ek): 10% (kb. 2 850 Ft)
A kedvezmény csak az 'Értesítés a kedvenc témákról' hírlevelünk címzettjeinek rendeléseire érvényes.
Kattintson ide a feliratkozáshoz
Kattintson ide a feliratkozáshoz
Beszerezhetőség:
Becsült beszerzési idő: Általában 3-5 hét.
A Prosperónál jelenleg nincsen raktáron.
Nem tudnak pontosabbat?
A Prosperónál jelenleg nincsen raktáron.
A termék adatai:
| ISBN13: | 9780190920197 |
| ISBN10: | 019092019X |
| Kötéstípus: | Puhakötés |
| Terjedelem: | 384 oldal |
| Méret: | 254x177x19 mm |
| Súly: | 704 g |
| Nyelv: | angol |
| 269 |
Témakör:
Hosszú leírás:
Substance Use Disorders provides an overview of substance misuse and addresses the neurobiology, pharmacotherapy, and behavioural therapy management of substance use disorders from a clinical perspective. Examining the opioid epidemic to frame its discussion of the epidemiology of substance misuse, this book explores common barriers that prevent the implementation of effective treatment. Chapters discuss various aspects of substance use disorders,
particularly opioids, alcohol, cannabis, and cocaine, to inform better conceptualization and management of these conditions. Part of the Primer On Psychiatry series, this book will provide a solid foundation for residents and fellows in psychiatry and addiction medicine and can also be used in clinical
practice.
particularly opioids, alcohol, cannabis, and cocaine, to inform better conceptualization and management of these conditions. Part of the Primer On Psychiatry series, this book will provide a solid foundation for residents and fellows in psychiatry and addiction medicine and can also be used in clinical
practice.
Tartalomjegyzék:
Chapter 1: Epidemiology of Substance Use Disorders: Opioid Use Disorder Epidemic
Chapter 2: Epidemiology of Cannabis Use Disorder: Neural Substrates & Treatment
Chapter 3: Preclinical Models of Substance Use Disorder: Abuse Liability Assessment and Candidate Pharmacotherapy Evaluation
Chapter 4: Impulsivity and Drug-Seeking Behavior in Substance Misuse: A Preclinical Perspective
Chapter 5: Impulsivity and Cue Reactivity in Substance Misuse: Clinical Studies
Chapter 6: Stress and Substance Misuse
Chapter 7: Overview: Barriers and Advantages of Utilization of FDA Approved Medications for Substance Use Disorder
Chapter 8: Methadone for Opioid Use Disorder
Chapter 9: Use of Buprenorphine for the Treatment of Opioid Use Disorder
Chapter 10: Antagonist Treatment for Opioid Use Disorder: Development of Antagonist Treatment. Antagonists vs. Agonist Treatments Pros and Cons
Chapter 11: Pharmacotherapy for Opioid Use Disorders in Special Populations
Chapter 12: Pharmacology of Alcohol Use Disorder
Chapter 13: Pharmacotherapy for Smoking Cessation: Overview of Medications Including Over-the-Counter Nicotine Replacement Therapy, Bupropion and Varenicline
Chapter 14: What is "Evidence Based" Treatment?
Chapter 15: Evidence Based Behavioral Therapies for Substance Use Disorder
Chapter 16: Evidence Based Pharmacotherapy for Cocaine, Amphetamine, and Methamphetamine Use Disorder: Overview and History of Clinical Trials
Chapter 17: Evidence Based Pharmacotherapy for Alcohol Use Disorder
Chapter 18: Turn the Next Page: Envisioning the Future of Addiction Therapeutics
Chapter 2: Epidemiology of Cannabis Use Disorder: Neural Substrates & Treatment
Chapter 3: Preclinical Models of Substance Use Disorder: Abuse Liability Assessment and Candidate Pharmacotherapy Evaluation
Chapter 4: Impulsivity and Drug-Seeking Behavior in Substance Misuse: A Preclinical Perspective
Chapter 5: Impulsivity and Cue Reactivity in Substance Misuse: Clinical Studies
Chapter 6: Stress and Substance Misuse
Chapter 7: Overview: Barriers and Advantages of Utilization of FDA Approved Medications for Substance Use Disorder
Chapter 8: Methadone for Opioid Use Disorder
Chapter 9: Use of Buprenorphine for the Treatment of Opioid Use Disorder
Chapter 10: Antagonist Treatment for Opioid Use Disorder: Development of Antagonist Treatment. Antagonists vs. Agonist Treatments Pros and Cons
Chapter 11: Pharmacotherapy for Opioid Use Disorders in Special Populations
Chapter 12: Pharmacology of Alcohol Use Disorder
Chapter 13: Pharmacotherapy for Smoking Cessation: Overview of Medications Including Over-the-Counter Nicotine Replacement Therapy, Bupropion and Varenicline
Chapter 14: What is "Evidence Based" Treatment?
Chapter 15: Evidence Based Behavioral Therapies for Substance Use Disorder
Chapter 16: Evidence Based Pharmacotherapy for Cocaine, Amphetamine, and Methamphetamine Use Disorder: Overview and History of Clinical Trials
Chapter 17: Evidence Based Pharmacotherapy for Alcohol Use Disorder
Chapter 18: Turn the Next Page: Envisioning the Future of Addiction Therapeutics
